About this trial
In recent years, the growing awareness of the multifactorial nature of neurodevelopmental disorders has stimulated interest in transdiagnostic approaches aimed at investigating underlying etiological mechanisms beyond traditional diagnostic categories. In this context, the present study seeks to provide a transdiagnostic profiling of both domain-general cognitive functions (attention, working memory, executive control) and domain-specific functions (phonological awareness, rapid naming, vocabulary, reading) underlying the main neurodevelopmental disorders in a large sample of preschool and school-age children (3-11 years), through the use of CRAB (Computerized Reading-related Assessment Battery). CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders. In particular, participating families will receive an email containing a link to access the CRAB platform, which will not include their personal data but rather a code provided by the staff of IRCCS Medea. A screen will open displaying several game-like tasks designed to measure both domain-general and domain-specific cognitive functions, which must be completed by the participating subject. The main objective is to obtain a fine-grained and multidimensional mapping of cognitive profiles prior to the standard diagnostic process, in order to identify early patterns of (a)typical or at-risk functioning.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 3 and 11 years;
First access to the NPIA service at IRCCS Eugenio Medea (Bosisio Parini);
Suspected neurodevelopmental or psychopathological disorder;
Completion of the standard clinical diagnostic pathway;
Disqualifiers
Age outside the specified range;
Failure to complete the diagnostic pathway;
Lack of access to a compatible device (for remote administration);
Severe sensory impairments (uncorrected blindness or deafness);
Trial population
The study population consists of children referred for the first time to the Territorial Unit of Child and Adolescent Neuropsychiatry (NPIA) at IRCCS Eugenio Medea - Associazione "La Nostra Famiglia", Bosisio Parini (LC), for suspected neurodevelopmental or psychopathological disorders. The project will be proposed to all children aged 3 to 11 years (from the first year of preschool to the fifth year of primary school). This is a heterogeneous population reflecting the variety of profiles typically seen in neuropsychiatric services, including suspected neurodevelopmental disorders (e.g., reading disorders, ADHD, language disorders, developmental coordination disorder), learning difficulties, or other clinical concerns. The study does not involve interventions or group allocation, but only a single digital data collection via CRAB prior to the standard diagnostic process.
Trial design
Case-only
Prospective
Treatments tested in this trial
Neuropsychological assessment
Diagnostic testCRAB (Computerized Reading-related Assessment Battery). CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders
Treatment groups
Trial outcomes
Primary outcomes
READING DECODING
the ability to read single words (pseudowords) fluently and accurately as ad hoc developed within CRAB;
RECEPTIVE VOCABULARY
the ability to select the picture that corresponds to a verbally presented target word (accuracy) as ad hoc developed within CRAB
PHONEME DELETION
the ability to repeat a (pseudo)word after cutting its first phoneme (accuracy) as ad hoc developed within CRAB
VISUAL ORTHOGRAPHIC
the ability to visually process both orthographic (letter-based) and non-orthographic (symbol-based) stimuli (accuracy) as ad hoc developed within CRAB
Secondary outcomes
identification of transdiagnostic cognitive clusters
to identify clusters of general and/or specific domain parameters (accuracy and/or speed) which mostly characterize different neurodevelopmental disorders (within disorder and between disorders).
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
IRCCS Eugenio Medea
Lead sponsor
Scuola Universitaria Professionale della Svizzera Italiana (SUPSI)
Collaborator
University of Geneva, Switzerland
Collaborator
This trial is not recruiting at the moment. You can still explore other options: